Viewing StudyNCT00403052



Ignite Creation Date: 2024-05-05 @ 5:11 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00403052
Status: TERMINATED
Last Update Posted: 2019-04-16
First Post: 2006-11-21

Brief Title: A Study of 1018 Immunostimulatory Sequence ISS Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer
Sponsor:
Organization: Dynavax Technologies Corporation